Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
89bio, Inc. (ETNB)  
$9.22 0.36 (4.06%) as of 4:30 Fri 5/3


Download
   
Exchange: N/A
Security Type: Common
Shares Out: 97,871,000
Market Cap: 902.37(M)
Last Volume: 0 Avg Vol: 0
52 Week Range: $6.66 - $22.03
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:
   

Rankings:
     
Insider 3 Months    : 20.2
Insider 6 Months    : 20.2
Insider 3/6 Months : 40.8
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   89bio is a clinical-stage biopharmaceutical company focused on the development and commercialization of therapies for the treatment of liver and cardio-metabolic diseases. Co.'s primary product candidate, pegozafermin, a glycoPEGylated analog of fibroblast growth factor 21 (FGF21), is being developed for the treatment of nonalcoholic steatohepatitis (NASH) and for the treatment of severe hypertriglyceridemia. FGF21 is a metabolic hormone that regulates energy expenditure and glucose and lipid metabolism. FGF21 analogs represent a class of drugs to treat NASH, because they not only address the liver manifestations, but also have an effect on the multiple co-morbidities that worsen NASH.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 1,350,000 1,350,000 1,350,000 7,862,717
Total Buy Value $20,722,500 $20,722,500 $20,722,500 $80,687,796
Total People Bought 1 1 1 2
Total Buy Transactions 1 1 1 5
Total Shares Sold 57,195 107,195 154,628 206,908
Total Sell Value $623,326 $1,183,326 $2,078,063 $2,842,845
Total People Sold 1 1 4 5
Total Sell Transactions 2 3 7 15
End Date 2024-02-04 2023-11-03 2023-05-05 2022-05-05

   
Records found: 190
  Page 2 of 8  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Mansbach Harry H Chief Medical Officer   •       –      –    2024-01-05 4 D $11.53 $111,507 D/D (9,671) 115,491     -
   Mansbach Harry H Chief Medical Officer   •       –      –    2024-01-05 4 A $0.00 $0 D/D 25,000 125,162     -
   Palekar Rohan Chief Executive Officer   •       •      –    2024-01-05 4 D $11.53 $317,202 D/D (27,511) 348,714     -
   Palekar Rohan Chief Executive Officer   •       •      –    2024-01-05 4 A $0.00 $0 D/D 75,000 376,225     -
   Palekar Rohan Chief Executive Officer   •       •      –    2023-12-29 4 AS $11.20 $560,000 D/D (50,000) 301,225 -17%     
   Palekar Rohan Chief Executive Officer   •       •      –    2023-12-29 4 OE $1.93 $96,500 D/D 50,000 351,225     -
   Le-Nguyen Quoc See Remarks   •       –      –    2023-09-09 4 D $16.61 $82,352 D/D (4,958) 163,874     -
   Mansbach Harry H Chief Medical Officer   •       –      –    2023-09-09 4 D $16.61 $63,467 D/D (3,821) 100,162     -
   Martins Ryan Chief Financial Officer   •       –      –    2023-09-09 4 D $16.61 $34,449 D/D (2,074) 54,221     -
   Martins Ryan Chief Financial Officer   •       –      –    2023-08-17 4 D $15.46 $11,641 D/D (753) 56,295     -
   Palekar Rohan Chief Executive Officer   •       •      –    2023-08-17 4 D $15.46 $69,585 D/D (4,501) 300,950     -
   Mansbach Harry H Chief Medical Officer   •       –      –    2023-08-17 4 D $15.46 $15,676 D/D (1,014) 103,983     -
   Le-Nguyen Quoc See Remarks   •       –      –    2023-08-01 4 D $15.46 $24,701 D/D (1,591) 168,832     -
   Martins Ryan Chief Financial Officer   •       –      –    2023-08-01 4 D $15.64 $5,411 D/D (346) 57,048     -
   Mansbach Harry H Chief Medical Officer   •       –      –    2023-08-01 4 D $15.64 $9,024 D/D (577) 104,997     -
   Laporte Kathleen   –       •      –    2023-07-17 4 S $18.80 $235,000 D/D (12,500) 0 59%     
   Laporte Kathleen   –       •      –    2023-07-17 4 OE $2.64 $33,000 D/D 12,500 12,500     -
   Mansbach Harry H Chief Medical Officer   •       –      –    2023-06-30 4 D $18.95 $54,614 D/D (2,882) 105,574     -
   Mansbach Harry H Chief Medical Officer   •       –      –    2023-06-30 4 A $0.00 $0 D/D 8,334 108,456     -
   Palekar Rohan Chief Executive Officer   •       •      –    2023-06-30 4 D $18.95 $313,187 D/D (16,527) 305,451     -
   Palekar Rohan Chief Executive Officer   •       •      –    2023-06-30 4 A $0.00 $0 D/D 33,334 321,978     -
   Le-Nguyen Quoc See Remarks   •       –      –    2023-06-30 4 D $18.95 $54,614 D/D (2,882) 170,423     -
   Le-Nguyen Quoc See Remarks   •       –      –    2023-06-30 4 A $0.00 $0 D/D 8,334 173,305     -
   Martins Ryan Chief Financial Officer   •       –      –    2023-06-30 4 D $18.95 $38,241 D/D (2,018) 57,394     -
   Martins Ryan Chief Financial Officer   •       –      –    2023-06-30 4 A $0.00 $0 D/D 5,834 59,412     -
  190 Records found
  1  2  3  4  5  6  7  8   
  Page 2 of 8
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us